α--tocopherol ether linked acetic acid (α--TEA) is a Vitamin E derivative with antineoplastic and anti--metastatic properties, tumor specificity, and immunogenic characteristics. The compound is structurally similar to vitamin E, however a key difference is that it doesn't retain any antioxidant properties. Interestingly, orally administered α--TEA appears to stimulate anti--tumor immunity, which, along with its anti--metastatic and antineoplastic properties, makes the molecule's mechanism of action worth investigating. Due to the loss of its anti--oxidative properties, the production of reactive oxygen species (ROS) and the cell viability of murine and human cancer cells treated with α--TEA, was analyzed over time. To determine the role that ROS play in inducing cell death, tumor cells were treated with α--TEA in the presence of reduced L--Glutathione (GSH), or the soluble form of vitamin E (TPGS; D--α--tocopheryl polyethylene glycol succinate). We also assessed the mechanism by which α--TEA affected cell death by screening for the expression of Major Histocompatibility Complex (MHC) Class I and II and the non classical MHC protein CD1d, as well as that of cell surface markers associated with immunogenic cell death (ICD), such as calreticulin. Surprisingly, our data revealed that α--TEA treatment induced ROS, but that cell death was only reduced when utilizing TPGS as an antioxidant, and not when GHS was present. Further analysis revealed that α--TEA doesn't induce ICD in all tumor cells, but may do so in certain cell lines. Overall, our findings support the hypothesis that α--TEA induces apoptosis in cancer cells through ROS build up, and that when this pathway is blocked, these ROS will initiate death through the formation of the Mitochondrial Permeability Transition Pore (MPTP), or damage to the rough Endoplasmic Reticulum.
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Introduction Breast cancer is the most common cancer among women worldwide. Within the United States alone, it is estimated that this type of cancer is diagnosed in over 200,000
women each year of whom 40,000 will eventually succumb to the disease. Several different strategies have been explored as a means to either treat or prevent breast cancer, and there has been speculation about the supplementation of antioxidants as a possible prevention and treatment strategies for this and other types of cancers 1 . Antioxidants are a plausible alternative to conventional cancer treatment because they reduce the amount of reactive oxygen species (ROS) within cells. ROS are very reactive chemical compounds with the ability to damage cell machinery and genetic material, thus potentially inducing mutations that can convert regular cells into cancerous cells 2 . Vitamin E (α--tocopherol) was identified as a supplement with cancer prevention potential, for its anti--oxidative role in cell membranes. Consequently Vitamin E and several synthesized analogs have been tested for their efficacy to treat or prevent cancer 3 . Surprisingly, two large studies revealed that vitamin E supplementation did not reduce the probability of developing cancer. Contrary to what was hypothesized, a study looking at the occurrence of prostate cancer in males with or without vitamin E supplementation found that a high dose of vitamin E supplementation actually increased the probability of developing prostate cancer − a finding that led to the premature termination of the study. Interestingly, a separate set of studies found that some vitamin E derivatives did possess anti--tumor properties 3, 4 . Alpha tocopherol ether linked acetic acid (α--TEA) is one of those derivatives, and oral administration of this analogue has been reported to slow tumor progression, reduce metastasis and increase the immunogenicity of tumors in several murine cancer models [5] [6] [7] [8] [9] . α--TEA is derived from vitamin E by replacing the hydroxyl group of the 6 th carbon of the Chroman Head with an acetic acid residue bonded to the carbon through an ether bond. This replacement renders the molecule redox silent but gives it antineoplastic properties 6,7,9,10 .
α--TEA's Mechanism of Action; the Current Models
Studies have proposed that α--TEA functions by apoptosis induction through both the intrinsic and an extrinsic pathway 3 . Nonetheless blockade of pro--apoptotic signaling does not stop cell death of cells treated with α--TEA, hinting that a second pathway operates in α--TEA's mechanism of action 9 . A report from Li, et al, proposed that autophagocytosis was the second pathway by which α--TEA killed cells. They hypothesized that autophagosomes formed in the process of α--TEA--induced cell death provided an ideal source of tumor antigens for antigen presenting cells (APCs) and that consequently, these could initiate a more pronounced anti--tumor immune response 9, 11 . While both the autophagocytosis and the apoptosis pathways may explain why α--TEA induces cell death, it is unclear how these methods account for the drug's tumor specificity and anti--metastatic properties.
ROS--induced Cell Death as α--TEA's Mechanism of Action
A model that has the potential to better explain the properties of α--TEA is that of cell death induced by the buildup of ROS. Noncancerous cells maintain a homeostatic balance of ROS.
These species, which are generated in abundance by the mitochondria, have been observed to act as secondary messengers for signal transduction pathways and as components of different processes, where they play a role in normal cell function 2, 12 Some tumor cells keep these high levels of ROS in check by producing an abnormally high level of antioxidants, thus maintaining conditions in which proliferation is favored 13 . As a result, some cancerous cells may be inherently more vulnerable to ROS--induced apoptosis or ROS--induced MPTP induced death, due to their already high baseline levels of ROS production.
While there are no studies showing a relationship between α--TEA and ROS production, there are studies on structurally similar analogs, like α--TOS that indicate that ROS play a pivotal role in the drugs' capabilities of inducing cell death 3, 14 . It is likely that due to the structural similarity that α--TEA and these compounds share, that α--TEA also induces or increases ROS levels in cells. Being more metabolically active than normal somatic cells, cancerous cells would be affected more by high levels of ROS. Therefore, ROS--induced apoptosis may be the primary mechanism by which α--TEA slows tumor progression, and ROS--induced MPTP induced death, might be a secondary pathway by which α--TEA induces cell death.
α--TEA and immunogenicity
The vitamin E derived α--TEA also possesses immunogenic properties. Previous analyses of implanted 4T1 mammary carcinoma tumors in mice that were given a diet containing α--TEA, have shown that there is an increased amount of CD4 + and CD8 + T--Cells compared to 
Materials and Methods
Cell Culture
Murine 4T1 and TUBO and human MDA--MB 231 and MCF7 breast cancer cell lines were cultured in RPMI with 10% FBS (Fetal Bovine Serum), 1% Sodium Pyruvate, 1%
NEAA (Non--Essential Amino Acids) solution, 1% HEPES and 1% Pen/Strep/ Glut (penicillin, streptomycin, and glutamine) solution.
Assessing α--TEA's reactive oxygen species production
The abovementioned cell lines were plated onto flat bottom 96--well plates at 25%
confluence and allowed to grow to confluency. Subsequently, the cells were administered treatments of 0, 30--, 60--, 120--, or a 240 μM α--TEA in groups of 6 wells. The α--TEA utilized through all experiments was conjugated to a lysine salt in order to increase its solubility.
The 
Evaluating the STING Pathway
To evaluate whether the STING pathway is at play in α--TEA treated cells, the presence of P--TBK, P--IRF3, and STING was analyzed through western blotting. 4T1 mammary carcinoma in PBS, the membranes were incubated with Fluorophore--conjugated Goat α--Rabbit polyclonal antibodies (LiCor) for 2 hours at room temperature in the dark. The membranes were washed as before and imaged utilizing a LiCor Oddyssey infrared scanner. After imagining the membranes, they incubated for 20 min in stripping buffer (Odyssey) at room temperature and then, after washing, the membrane previously blotted for P--TBK, and the membrane previously blotted for P--IRF 3 were incubated overnight at 4°C with TBK, and IRF3 Rabbit anti--mouse monoclonal antibodies (Cell Signaling), respectively. Following the incubation, the membranes were washed and incubated with secondary antibody as previously described, and then imaged in a LiCor Infrared scanner.
Statistical Analyses
Differences between groups of individual experiments in time course assays were analyzed through a two way ANOVA with Tukey HSD test. Differences in variance between groups in experiments with only one time point were evaluated through simple one way ANOVA with Tukey HSD test. All values with P< 0.05 were regarded as statistically significant, and all statistical analyses were done using Prism 6 graphing software (GraphPad). The most surprising result came from the MCF--7 cell lines, which had ROS levels at and below the basal ROS production rates at the 120 μM and 240 μM concentrations of α--TEA respectively, but had significantly higher levels of ROS at the 30 μM and 60 μM concentrations. As was the trend with the TUBO cell line, the death rate of MCF--7 cell was dose dependent, but did not correlate with ROS species levels for any but the 60 μM concentration in which cells began dying after a significant increase in ROS levels. In addition, at the concentrations in which ROS levels augmented, the rise in ROS began at an earlier time point than in the murine cell lines -roughly 5 hours after treatment.
Likewise ROS levels between the control and the treatment group commenced to diverge much sooner in MDA--MB--231 cells at all concentrations except the highest one. Although the highest levels of reactive oxygen species were produced by the highest concentration at the latest time point, this concentration didn't significantly diverge from the control until 25 hours after the experiment began. The second highest concentration induced a rise in ROS early on, but the ROS levels plateaued and commenced to pick back up 25 hours after treatment first began. In both these instances, cell death occurred sooner than the production of ROS, which could have been the cause of the phenomenon. The levels of ROS at the lower concentrations, however, rose steadily over time. At the 60 μM α--TEA concentration, cell death occurred after ROS levels increased by a significant amount, yet at the 30 μM concentration, no significant shift in death rate was visible, perhaps because the ROS levels during this time period were as high as they were when the death rate started to rise in cells treated with the 60 μM concentration.
ROS Induction and Cell Death in α--TEA Treated Cells
The levels of reactive oxygen species were reduced by the presence of either antioxidant (TPGS or GSH). However the viability of the cells was dependent on the identity of the antioxidant. While those cells treated with different dosages of GHS showed no decrease in cell death, in fact showed an increased amount of death at the higher GHS concentrations in the absence of ROS (data not shown), the cells treated with TPGS not only experienced a reduction of ROS, but also experienced a decrease in cell death. While TPGS alone caused death on its own, and α--TEA alone caused significantly more cell death than TPGS alone, when they were combined, they caused as much death as with TPGS alone, hinting that the death was only caused by the apparent slight toxicity of TPGS (Figure 2 ). Given that α--TEA has been observed to increase immunogenicity of 4T1 tumors in vivo, we analyzed whether this cell line activated the STING pathway through western blotting. 
Discussion
Dose Dependent Killing Mechanism
Due to its high degree of structural similarity to Vitamin E, it is very likely that α--TEA is located in the same cellular, sub--cellular, and extracellular compartments as the vitamin.
Vitamin E is found attached to lipoproteins, within the lipid membrane, and within membranes of sub--cellular compartments. Vitamin E concentration is highest in the microsomal, lysosomal, and mitochondrial fractions of lysed cells 22, 23 . Inside of the mitochondria, vitamin E is thought to prevent the peroxidation of lipids and it is thought to enter into a cycle with co--Enzyme Q, in which α--Tocopherol will accept a free radical and co--enzyme Q will reset it, allowing it to accept a new radical 23 . The distribution, as well as the dynamic that vitamin E has in the mitochondria and other organelles where ROS are present, helps explain the trends that are observed in the data.
At the higher α--TEA concentrations, cells die much faster, even before the levels of ROS begin to rise. At the lower concentrations, however, the levels of ROS start to increase at a higher rate than the rate of cell death. 
Death reduction by TPGS but not by GHS Reveals α--TEA's Location of Action
When the cells were treated with α--TEA and either one of two different types of antioxidants-GHS or TPGS -their production of ROS was lowered. Nonetheless, TPGS reduced α--TEA's ability to induce cell death, while GHS had no such effect on cell death.
This surprising finding provides an important insight into where α--TEA may be acting.
TPGS is also a vitamin E analog that is much more water--soluble, yet retains antioxidant activity after it is cleaved by cellular esterases, causing it to deliver α--tocopherol to the membranes. This compound is used as a vitamin E supplement and it is also utilized to facilitate the delivery of hydrophobic drugs to cells in the body through the plasma membrane. Thus, just like vitamin E, it would be found at its highest quantities in the microsomal, mitochondrial, and lysosomal fractions of lysed cells. The microsomal region is mostly formed by remnants of the rough endoplasmic reticulum (rER), smooth endoplasmic reticulum (sER) and cellular vesicles 24 . Therefore it is conceivable that TPGS and α--TEA would accumulate at this location. It just happens that GHS is found ubiquitously throughout the cell, with the only exception being the lumen of the rER 25 . While the presence of GSH throughout the cell would protect from the activity of ROS induced by α--TEA, GSH would not be able to protect the cell from the damage that increased amounts of ROS induced by α--TEA would cause in the rER. However, the chemical nature of TPGS allows it to reach the rER, where its anti--oxidative properties will protect cells from α--TEA's oxidative damage. Previous studies have correlated ER stress to α--TEA's mechanism of action 26 . So it is possible that α--TEA induces rER stress through ROS that will eventually lead to cell death. In the absence of added GSH, α--TEA may still provoke oxidative stress in other organelles, predominantly, in the mitochondria. There the damage can compromise the mitochondrial membrane, lead to the release of cytochrome C and initiate the apoptotic pathway. If this pathway is inhibited, the MPTP pathway would still trigger the halt of glycolysis and the cells would thus perish, if this pathway isn't enough, then elevated levels of ROS may cause enough rER damage to put protein synthesis into a halt and kill the cells.
α--TEA's Tumor Specificity in Relation to its Structure and the Production of ROS
The existing body of evidence suggests that the location of α--TEA within the cell plays an important role in how it works. But how does it specifically target tumor cells? This concept is not well understood, but it may be explained by the chemical properties of its analogue: α--Tocopherol. Due to their uncontrolled proliferation, tumor cells will have a high demand for membrane lipids, and so they will receive a higher supply of them through delivery of Low Density Lipoproteins (LDL) and High Density Lipoproteins (HDL). Vitamin E can be found in lipoproteins and α--TEA will likely be located there too. In this way α--TEA will be administered preferentially to tumor cells and they will accumulate a higher amount of α--TEA than non--cancerous tissue.
Cancerous cells will be more vulnerable to the production of ROS by α--TEA than normal somatic cells because they are more likely to have a more delicate ROS homeostasis 13 . In this way, while ROS has the capability of significantly lowering the number of tumor cells, it may have a reduced impact on non--cancerous cells.
The combination of vulnerability to ROS with cellular targeting may better explain the specificity that α--TEA and other similar compounds may have to tumor cells.
α--TEA's Capabilities of Inducing Immunogenic Cell Death
While there is compelling evidence suggesting that α--TEA has immunogenic properties in 4T1 cells in vitro 8 , it doesn't appear to involve changes to the direct interaction with lymphocytes via the overexpression of either MHC complex. Furthermore the secretion of intracellular proteins does not play a role in α--TEA's method of inducing an immunogenic response after cell death in 4T1 cells. In TUBO cells, the case is very similar, TUBO cells did have a statistically significantly higher expression of calreticulin and Grp 94, however, because the signal level for these markers is so low in this assay, it is questionable whether the spike in the expression of both of these proteins would have any biological significance.
Therefore, it appears unlikely that these observations are sufficient to account for the overall impact of α--TEA on anti--tumor immunity (Figure 3) . The pathway that is more likely to predominate across different cell lines is one that involves the phosphorylation of Subsequently the DNA would be detected by STING, which would initiate the pathway. Yet there are additional possibilities since STING is also found in the ER, which is an organelle where α--TEA appears to have a direct impact 27 . ROS produced by α--TEA in the rER could directly interact with STING, or an oxidized product in the rER could interact with STING after it reacts with ROS.
